Zodiac Mediquip Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 12-01-2024
- Paid Up Capital ₹ 1.07 M
as on 12-01-2024
- Company Age 25 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 100.65%
(FY 2022)
- Profit 18.67%
(FY 2022)
- Ebitda -617.06%
(FY 2022)
- Net Worth 6.91%
(FY 2022)
- Total Assets 38.19%
(FY 2022)
About Zodiac Mediquip
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 1.07 M, as per Ministry of Corporate Affairs (MCA) records.
Kairavbhai Shah, Darshini Shah, and Shanay Shah serve as directors at the Company.
- CIN/LLPIN
U46596GJ1999PLC036542
- Company No.
036542
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Sep 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Zodiac Mediquip?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kairavbhai Shah  | Director | 01-Apr-2000 | Current |
| Darshini Shah | Director | 08-Sep-1999 | Current |
| Shanay Shah | Director | 25-Jul-2009 | Current |
Financial Performance and Corporate Structure Insights of Zodiac Mediquip.
Zodiac Mediquip Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 100.65% increase. The company also saw a substantial improvement in profitability, with a 18.67% increase in profit. The company's net worth moved up by a moderate rise of 6.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zodiac Mediquip?
In 2020, Zodiac Mediquip had a promoter holding of 99.96% and a public holding of 0.04%. The company had 1 Subsidiary and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Slaney Healthcare Private LimitedActive 16 years 11 monthsDarshini Shah and Shanay Shah are mutual person
Uranus Medical Devices LimitedActive 18 years 11 monthsDarshini Shah and Shanay Shah are mutual person
- Shalby Advanced Technologies India Private LimitedActive 8 months 8 days
Shanay Shah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zodiac Mediquip?
Unlock and access historical data on people associated with Zodiac Mediquip, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zodiac Mediquip, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zodiac Mediquip's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
